Croda International PLC
Croda offers high-purity multicompendial excipients for topical, parenteral, ophthalmic and oral dosage forms. Featured products include Omega-3 Fatty Acid Concentrates and Super Refined® range of polar and nonpolar excipients.
Website: www.croda.com/healthcare
E-mail: hc-europe@croda.com
Croda International Plc is a UK-based manufacturer and worldwide supplier of oleochemicals offering one of the widest ranges of chemical specialties, surfactants, and high-purity lipids available to the pharmaceutical industry with products manufactured at multiple sites throughout the world.
Croda manufactures excipients of superior quality and purity for the global pharmaceutical market. Croda developed and utilises a proprietary flash chromatographic process called Super Refining™. This process physically removes impurities from pharmaceutical excipients without altering their fundamental structure in any way. This process allows the offering of a range of high purity excipients that can improve API and formulation stability.
Croda offers a complete range of products for topical dosage forms as well as high-purity multicompendial solvents, solubilisers and surfactants suitable for parenteral, oral and ophthalmic formulations. Featured products include Super Refined™ ingredients: Oils, Oleic Acid, Oleyl Alcohol, Isopropyl Myristate, PEGs, Polysorbates, Dimethyl Isosorbide, Medical Grade Lanolins, Poloxamers and Omega 3 Fatty Acid Concentrates.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications
May 5th 2025Don't miss this webinar delving into: - How to streamline the selection of the primary container and delivery device - How to overcome silicone challenges in PFSs - How to enhance the delivery of highly viscous drug formulation
Solving the Silicone Challenge in Pre-fillable Syringes
May 5th 2025The release of subvisible silicone particles and the risks associated with silicone oil droplets are major factors that can compromise the safety and efficacy of sensitive drugs. Download this white paper and discover how Stevanato Group's innovative syringe platform answers this challenge.
